DEPLOYDatabase

Deployment

LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA

Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.

LIBERTY Endovascular Robotic System by Microbot Medical · Catalog entry · 1 source · not yet field-verified · Surgical robots

Track LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA

Recent coverage

See all coverage →

First procedure in a patient using the LIBERTY endovascular robotic surgical system performed by Dmitry Rabkin, MD at Brigham and Women's Hospital as part of the pivotal clinical trial. LIBERTY investigational units shipped to BWH.

Safety record

No incidents on record for LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-09
Model
LIBERTY Endovascular Robotic System
Company
Microbot Medical
Location
Boston, Massachusetts, USA
Status
pilot
First seen
2024-07-01
ID
b3fa733e-8f42-4ddb-b08f-20514f1b4cd5

Timeline

  1. Jul 2024
    First recorded
    LIBERTY Endovascular Robotic System first documented operating at Boston, Massachusetts, USA.
  2. Aug 2026
    Current status: pilot, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

LIBERTY Endovascular Robotic System operates in Boston, Massachusetts, USA. Explore the full verified map:

Sources (1)

  1. https://evtoday.com/news/microbots-liberty-system-pivotal-trial-commences-enrollment
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA.

Common questions

What is the LIBERTY Endovascular Robotic System deployment at Boston, Massachusetts, USA?
LIBERTY Endovascular Robotic System, built by Microbot Medical, is recorded as a deployment at Boston, Massachusetts, USA on the DEPLOY registry. Microbot Medical operates the deployment directly.
Who operates LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA?
Microbot Medical, the manufacturer of LIBERTY Endovascular Robotic System, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the LIBERTY Endovascular Robotic System deployment at Boston, Massachusetts, USA go live?
The deployment is recorded as starting July 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the LIBERTY Endovascular Robotic System deployment at Boston, Massachusetts, USA?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces